🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Renal Transplant Rejection

Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection NCT05084768n/a1 site📍 Loma Linda Loma Linda University · Tests: Donor-derived cell-free DNA Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity NCT07134491n/a2 sites📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Piece of kidney removal, Stool collection, Blood collection Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation NCT06794970n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications NCT04877288Phase 338 sites📍 Birmingham📍 Los Angeles📍 Washington D.C. Bristol-Myers Squibb · Tests: Belatacept, Tacrolimus, Cyclosporine A, Mycophenolate Mofetil, Enteric Coated Mycophenolate Sodium Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring NCT07060716n/a10 sites📍 Los Angeles📍 Jacksonville📍 Tampa Insight Molecular Diagnostics · Tests: donor-derived cell-free DNA test Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies NCT05385432Phase 31 site📍 Tours University Hospital, Tours · Tests: Rabbit Anti thymocyte globulin (rATG), Basiliximab A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation NCT07412470Phase 2, Phase 373 sites📍 San Francisco📍 Atlanta📍 Hines Sanofi · Tests: Frexalimab, Frexalimab, Tacrolimus, rabbit anti-thymocyte globulin, mycophenolate mofetil Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection NCT07663669n/a1 site📍 Besançon Centre Hospitalier Universitaire de Besancon Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch NCT06493526Phase 41 site📍 Edegem University Hospital, Antwerp · Tests: Withdrawal of calcineurin-inhibitor, continue on concentration-controlled mycophenolate mofetil and corticosteroids. Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant NCT05027906Phase 1, Phase 29 sites📍 Cincinnati📍 Camperdown📍 Adelaide Eledon Pharmaceuticals · Tests: AT-1501 Proteogenomic Monitoring and Assessment of Liver Transplant Recipients NCT01644903n/a1 site📍 Chicago Northwestern University TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation NCT06829719NA4 sites📍 Bordeaux (France)📍 Lyon📍 Strasbourg (france) Hospices Civils de Lyon · Tests: TTV DNAemia, EQ-5D-5L questionnaire, Biological tests Empagliflozin Treatment in Kidney Transplant Recipients NCT06013865Phase 45 sites📍 Hines📍 Iowa City📍 Omaha VA Office of Research and Development · Tests: Empagliflozin Study of the Plasma and Urinary cfDNA of in Kidney Transplant Patients NCT06910527n/a1 site📍 Rouen Poulet Geoffroy Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor NCT03707262Phase 1, Phase 21 site📍 Los Angeles Jeffrey Veale, MD · Tests: Donor CD34+ and CD3+ cells Daratumumab for Late Antibody-Mediated Rejection NCT07081126NA1 site📍 Martin University Hospital, Martin · Tests: Daratumumab (Subcutaneously), control group A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients NCT05325008Phase 313 sites📍 Canberra📍 New Lambton Heights📍 Randwick The University of Queensland · Tests: Immunosuppression reduction/modification + intravenous immunoglobulin, Immunosuppression reduction/modification KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection NCT06830473n/a2 sites📍 Edinburgh📍 Glasgow University of Edinburgh Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During Chronic AntiBody-Mediated Rejection in Kidney Transplantation. NCT04870437NA4 sites📍 Besançon📍 Clermont-Ferrand📍 Saint-Etienne University Hospital, Angers · Tests: Extracorporeal phototherapy Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) in Kidney Transplant Recipients With Chronic Active Antibody-Mediated Rejection NCT07689578Phase 41 site📍 Chengdu Turun Song · Tests: BiTE (BCMA x CD3 Bispecific Antibody) A Multicenter Randomized Controlled Trial to Treat Acute T Cell Mediated Rejection in Kidney and Kidney-Pancreas Transplant Recipients NCT06474273Phase 330 sites📍 Lambton📍 Randwick📍 Westmead University of Sydney · Tests: Methylprednisolone, Prednisone Treatment of Antibody-Mediated Rejection (ABMR) With CarBel NCT06918990Phase 111 sites📍 Birmingham📍 Phoenix📍 Los Angeles National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Carfilzomib, Belatacept A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant NCT07508787Phase 214 sites📍 Sacramento📍 Tampa📍 Atlanta Nefro Avillion Clinical Development, LLC · Tests: Siplizumab, Rabbit anti-thymocyte globulin Belimumab to Mobilise Memory B-cells From Secondary Lymhoid Organs to Improve Memory B-cell HLA-specificity Profiling to Support Delisting for Transplant Access in Highly-sensitized NCT07539857Phase 21 site📍 Leiden Leiden University Medical Center · Tests: Belimumab Prefilled Syringe [Benlysta] Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab NCT07006532NA1 site📍 Tehran Shahid Beheshti University of Medical Sciences · Tests: Tocilizumab Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants NCT05525507Phase 11 site📍 Los Angeles University of California, Los Angeles · Tests: Conditioning and Stem cell infusion MR-proADM as a Early Biomarker for DGF and AR in Kidney and Liver Transplantation NCT06130046n/a1 site📍 Rome University of Rome Tor Vergata · Tests: MR-proADM dosage Platelet Aggregation in the Diagnosis of Acute Graft Rejection NCT07275541n/a1 site📍 Martin University Hospital, Martin TreaT-Assay: the New Frontier for the Diagnosis of Acute Rejection in Kidney Transplantation NCT06801262n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Trifecta-Kidney cfDNA-MMDx Study NCT04239703n/a31 sites📍 Tampa📍 Baltimore📍 Baltimore University of Alberta · Tests: MMDx, Prospera, HLA antibody
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy